[Skip to Content]
[Skip to Content Landing]
Other Articles
July 28, 1951


Author Affiliations

Director, National Cancer Institute, U. S. Public Health Service, Bethesda 14, Md.

JAMA. 1951;146(13):1248. doi:10.1001/jama.1951.03670130070024

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.


To the Editor:  —I wish to compliment the American Medical Association for its Special Bulletin No. 1, containing Mr. George E. Connery's excellent account of our activities in Bethesda titled "A Report on the National Cancer Institute." I note an omission, however, which I believe should be incorporated in the report in order to indicate the complete scope of the program of the institute. We have two clinical research programs, one at the Laboratory of Experimental Oncology in San Francisco and the other at the United States Marine Hospital in Baltimore.The Laboratory of Experimental Oncology, of which Dr. Michael B. Shimkin is chief, is a cooperative project on neoplastic diseases with the University of California School of Medicine. With the cancer patient as the focal point of investigation, the work of this laboratory is oriented along four broad approaches: (1) experimental therapy, providing clinical material for other studies as

First Page Preview View Large
First page PDF preview
First page PDF preview